Business Strategy for Investigational Gene and Cell Therapies
BioHeights LLC is a consulting company that specializes in business strategy for novel therapeutics. We pride ourselves on deep knowledge of the gene and cell therapy space. We are here to help small-, mid-, and large-size biopharmaceutical companies, startups, and academic spinouts, investigators, and technology transfer offices to develop best commercial and business strategy that informs preclinical, clinical, and regulatory path for your new technology and supports fundraising.
Sickle Cell Disease: Centers of Excellence And Gene Therapy
Sickle cell disease (SCD) is a hemoglobinopathy associated with defective ‘sickle’ red blood cells. Two hemoglobinopathies, β-thalassemia and SCD, are different in the following way. β-Thalassemia has low or absent production of β-globin, while SCD has defective β-globin due to a specific mutation leading to defective hemoglobin. In this article you will find insights about…
Ohio Cell and Vector Manufacturing Landscape
Note to readers: A short laymen version of this article with suggested problems and proposed solutions is published in Crain’s Cleveland Business. Here, we present a situation assessment for more advanced readers. If George Orwell were alive today, he could have pointed out that ‘all viruses are equal, but some viruses are more equal than…
Educational Webinars: Forecasting Principles And Tools
In partnership with Case Western Reserve University, we are giving educational webinars on business concepts used in the pharmaceutical and biotech industry including forecasting principles. These webinars are interactive and open to anyone interested. We had very positive feedback from a variety of attendees: entrepreneurs, lawyers, physicians, principle investigators, technology transfer office associates, life sciences…
We offer a variety of online tools including timeline of funding events and forecasting models connected to a disease prevalence/ incidence database and a database of probabilities of success by therapeutic area.
- Funding Events
- Risk-adjusted NPV
- NPV sensitivity analysis
Sign Up to Receive the Latest Insights
Enter your email address to receive notifications about new articles, tools, and updates.
Sign Up Here